September 2023 - PharmaTimes

Published on 30 August 2023

Description:

New PT is out now, with a razor-sharp focus on the importance of youth in shaping the future of our industry. We’ll also be taking on antimicrobial resistance, dissecting mergers & acquisitions and – of course – pondering whether viruses are dead or alive. Meanwhile, as wider healthcare emerges into a new era, we will also explore how the enduring relationship between NHS and pharma will evolve. There are also further intrepid musings around AI, real-life data and targeted therapies.

Categories:

PharmaTimes

25 articles from this collection:

Cover

2 - FlyPharma Europe

3 - From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. As the analysis shows, a relentless focus on innovation and a determination to solve problems hindering patient outcomes are key traits that have helped those at the top shine in a sector that saw average growth of 33% in 2020.

4-5 - Contents

6 - NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

7 - NEWS: NHS

8 - NEWS: Research

9 - NEWS: Conditions

10-12 - COVER STORY: Opening Doors

13 - Tillotts Pharma

14-15 - EDI

16-17 - VIRUSES

18-19 - PHARMA: Resistance is futile?

20-22 - MERGERS - The human league

23 - GENERICS - Same to you

24-25 - MEDICINE - Local heroes

26-28 - NHS: Taking off together!

29 - THOUGHT LEADER: Revolution vs renovation

30-31 - DATA - Back to life (back to reality)

32-33 - FUTURE: History channel

34-35 - MEDICINES - The great debate

36-37 - Your moves

38 - AI: Analyse this

39 - PHARMATIMES AWRDS

40 - PMPS

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/